IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Casi Pharmaceuticals Inc (CASIF)

CUSIP: G1933S901 | Healthcare · Biotechnology | Micro Cap | 3 institutional holders

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile